Excluding children from COVID-19 clinical trials may limit their treatment options
A new viewpoint article from Harvard Medical School, published in the journal JAMA Pediatrics, discusses the hesitancy to include children in coronavirus disease 2019 (COVID-19) clinical trials, potentially diminishing their therapeutic options in the long run.
.png)
No hay comentarios:
Publicar un comentario